CTLA4 mediated targeting enhances immunogenicity against PRRSV in a DNA prime/killed virus boost strategy

Veterinary Immunology and Immunopathology

Volumn 154, Issue 3-4, 2013, Pages 121-128

  Wang, Yalan ^a   Zhao, Haiyan ^a   Ma, Zhitao ^a   Wang, Yongqiang ^a   Feng, Wen hai ^a  

^a CHINA AGRICULTURAL UNIVERSITY   (China)

Author keywords

CTLA4; GP5; Heterologous prime boost; PRRSV; Vaccine

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INACTIVATED VACCINE; INTERLEUKIN 4; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANTIGEN PRESENTING CELL; ARTERIVIRUS; ARTERIVIRUS INFECTION; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; VACCINATION;

ANIMALS; ANTIBODIES, VIRAL; CELL PROLIFERATION; CTLA-4 ANTIGEN; CYTOKINES; DNA, VIRAL; GENE EXPRESSION REGULATION; IMMUNITY, HUMORAL; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; LYMPHOCYTES; MICE; MICE, INBRED BALB C; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; VACCINES, DNA; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

MUS; PORCINE RESPIRATORY AND REPRODUCTIVE SYNDROME VIRUS; SUIDAE; SUS;

EID: 84880135866     PISSN: 01652427     EISSN: 18732534     Source Type: Journal    
DOI: 10.1016/j.vetimm.2013.05.008     Document Type: Article

References (40)

1. Amara R.R., Villinger F., Altman J.D., Lydy S.L., O'Neil S.P., Staprans S.I., Montefiori D.C., Xu Y., Herndon J.G., Wyatt L.S., Candido M.A., Kozyr N.L., Earl P.L., Smith J.M., Ma H.L., Grimm B.D., Hulsey M.L., Miller J., McClure H.M., McNicholl J.M., Moss B., Robinson H.L. Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 2001, 292:69-74.
2. Boyle J.S., Brady J.L., Lew A.M. Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction. Nature 1998, 392:408-411.
3. Cao J., Wang X., Du Y., Li Y., Jiang P. CD40 ligand expressed in adenovirus can improve the immunogenicity of the GP3 and GP5 of porcine reproductive and respiratory syndrome virus in swine. Vaccine 2010, 28:7514-7522.
4. Conzelmann K.K., Visser N., Van Woensel P., Thiel H.J. Molecular characterization of porcine reproductive and respiratory syndrome virus, a member of the arterivirus group. Virology 1993, 193:329-339.
5. Darnell M.E., Subbarao K., Feinstone S.M., Taylor D.R. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J. Virol. Methods 2004, 121:85-91.
6. Dea S., Gagnon C.A., Mardassi H., Pirzadeh B., Rogan D. Current knowledge on the structural proteins of porcine reproductive and respiratory syndrome (PRRS) virus: comparison of the North American and European isolates. Arch. Virol 2000, 145:659-688.
7. Dee S., Otake S., Deen J. An evaluation of ultraviolet light (UV254) as a means to inactivate porcine reproductive and respiratory syndrome virus on common farm surfaces and materials. Vet. Microbiol. 2011, 150:96-99.
8. Deliyannis G., Boyle J.S., Brady J.L., Brown L.E., Lew A.M. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:6676-6680.
9. Delputte P.L., Meerts P., Costers S., Nauwynck H.J. Effect of virus-specific antibodies on attachment, internalization and infection of porcine reproductive and respiratory syndrome virus in primary macrophages. Vet. Immunol. Immunopathol. 2004, 102:179-188.
10. Firth A.E., Zevenhoven-Dobbe J.C., Wills N.M., Go Y.Y., Balasuriya U.B., Atkins J.F., Snijder E.J., Posthuma C.C. Discovery of a small arterivirus gene that overlaps the GP5 coding sequence and is important for virus production. J. Gen. Virol. 2011, 92:1097-1106.
11. Goyal S.M. Porcine reproductive and respiratory syndrome. J. Vet. Diagn. Invest. 1993, 5:656-664.
12. Hou Y.H., Chen J., Tong G.Z., Tian Z.J., Zhou Y.J., Li G.X., Li X., Peng J.M., An T.Q., Yang H.C. A recombinant plasmid co-expressing swine ubiquitin and the GP5 encoding-gene of porcine reproductive and respiratory syndrome virus induces protective immunity in piglets. Vaccine 2008, 26:1438-1449.
13. Jiang Y., Xiao S., Fang L., Yu X., Song Y., Niu C., Chen H. DNA vaccines co-expressing GP5 and M proteins of porcine reproductive and respiratory syndrome virus (PRRSV) display enhanced immunogenicity. Vaccine 2006, 24:2869-2879.
14. Jiang W., Jiang P., Wang X., Li Y., Du Y. Enhanced immune responses of mice inoculated recombinant adenoviruses expressing GP5 by fusion with GP3 and/or GP4 of PRRS virus. Virus Res. 2008, 136:50-57.
15. Kennedy N.J., Spithill T.W., Tennent J., Wood P.R., Piedrafita D. DNA vaccines in sheep: CTLA-4 mediated targeting and CpG motifs enhance immunogenicity in a DNA prime/protein boost strategy. Vaccine 2006, 24:970-979.
16. Li Y., Wang X., Bo K., Tang B., Yang B., Jiang W., Jiang P. Emergence of a highly pathogenic porcine reproductive and respiratory syndrome virus in the Mid-Eastern region of China. Vet. J. 2007, 174:577-584.
17. Li B., Xiao S., Wang Y., Xu S., Jiang Y., Chen H., Fang L. Immunogenicity of the highly pathogenic porcine reproductive and respiratory syndrome virus GP5 protein encoded by a synthetic ORF5 gene. Vaccine 2009, 27:1957-1963.
18. Lillehoj H.S. Immune response during coccidiosis in SC and FP chickens. I. In vitro assessment of T cell proliferation response to stage-specific parasite antigens. Vet. Immunol. Immunopathol. 1986, 13:321-330.
19. Liu L., Zhou X., Liu H., Xiang L., Yuan Z. CpG motif acts as a 'danger signal' and provides a T helper type 1-biased microenvironment for DNA vaccination. Immunology 2005, 115:223-230.
20. Lopez O.J., Osorio F.A. Role of neutralizing antibodies in PRRSV protective immunity. Vet. Immunol. Immunopathol. 2004, 102:155-163.
21. Lu S. Heterologous prime-boost vaccination. Curr. Opin. Immunol. 2009, 21:346-351.
22. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficacy and future vaccine development. Vet. Microbiol. 2000, 74:309-329.
23. Nayak B.P., Sailaja G., Jabbar A.M. Enhancement of gp120-specific immune responses by genetic vaccination with the human immunodeficiency virus type 1 envelope gene fused to the gene coding for soluble CTLA4. J. Virol. 2003, 77:10850-10861.
24. Nielsen H.S., Oleksiewicz M.B., Forsberg R., Stadejek T., Botner A., Storgaard T. Reversion of a live porcine reproductive and respiratory syndrome virus vaccine investigated by parallel mutations. J. Gen. Virol. 2001, 82:1263-1272.
25. Rossow K.D. Porcine reproductive and respiratory syndrome. Vet. Pathol. 1998, 35:1-20.
26. Shedlock D.J., Weiner D.B. DNA vaccination: antigen presentation and the induction of immunity. J. Leukoc. Biol. 2000, 68:793-806.
27. Shiver J.W., Fu T.M., Chen L., Casimiro D.R., Davies M.E., Evans R.K., Zhang Z.Q., Simon A.J., Trigona W.L., Dubey S.A., Huang L., Harris V.A., Long R.S., Liang X., Handt L., Schleif W.A., Zhu L., Freed D.C., Persaud N.V., Guan L., Punt K.S., Tang A., Chen M., Wilson K.A., Collins K.B., Heidecker G.J., Fernandez V.R., Perry H.C., Joyce J.G., Grimm K.M., Cook J.C., Keller P.M., Kresock D.S., Mach H., Troutman R.D., Isopi L.A., Williams D.M., Xu Z., Bohannon K.E., Volkin D.B., Montefiori D.C., Miura A., Krivulka G.R., Lifton M.A., Kuroda M.J., Schmitz J.E., Letvin N.L., Caulfield M.J., Bett A.J., Youil R., Kaslow D.C., Emini E.A. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 2002, 415:331-335.
28. Tachedjian M., Boyle J.S., Lew A.M., Horvatic B., Scheerlinck J.P., Tennent J.M., Andrew M.E. Gene gun immunization in a preclinical model is enhanced by B7 targeting. Vaccine 2003, 21:2900-2905.
29. Tian K., Yu X., Zhao T., Feng Y., Cao Z., Wang C., Hu Y., Chen X., Hu D., Tian X., Liu D., Zhang S., Deng X., Ding Y., Yang L., Zhang Y., Xiao H., Qiao M., Wang B., Hou L., Wang X., Yang X., Kang L., Sun M., Jin P., Wang S., Kitamura Y., Yan J., Gao G.F. Emergence of fatal PRRSV variants: unparalleled outbreaks of atypical PRRS in China and molecular dissection of the unique hallmark. PLoS One 2007, 2:e526.
30. Tong G.Z., Zhou Y.J., Hao X.F., Tian Z.J., An T.Q., Qiu H.J. Highly pathogenic porcine reproductive and respiratory syndrome, China. Emerg. Infect. Dis. 2007, 13:1434-1436.
31. Vanhee M., Delputte P.L., Delrue I., Geldhof M.F., Nauwynck H.J. Development of an experimental inactivated PRRSV vaccine that induces virus-neutralizing antibodies. Vet. Res. 2009, 40:63.
32. Vashisht K., Goldberg T.L., Husmann R.J., Schnitzlein W., Zuckermann F.A. Identification of immunodominant T-cell epitopes present in glycoprotein 5 of the North American genotype of porcine reproductive and respiratory syndrome virus. Vaccine 2008, 26:4747-4753.
33. Vaughan A.N., Malde P., Rogers N.J., Jackson I.M., Lechler R.I., Dorling A. Porcine CTLA4-Ig lacks a MYPPPY motif, binds inefficiently to human B7 and specifically suppresses human CD4+ T cell responses costimulated by pig but not human B7. J. Immunol. 2000, 165:3175-3181.
34. Wang S., Kennedy J.S., West K., Montefiori D.C., Coley S., Lawrence J., Shen S., Green S., Rothman A.L., Ennis F.A., Arthos J., Pal R., Markham P., Lu S. Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime-protein boost HIV-1 vaccine in healthy human volunteers. Vaccine 2008, 26:3947-3957.
35. Wang S., Parker C., Taaffe J., Solorzano A., Garcia-Sastre A., Lu S. Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses. Vaccine 2008, 26:3626-3633.
36. Wang X., Li J., Jiang P., Li Y., Zeshan B., Cao J. GM-CSF fused with GP3 and GP5 of porcine reproductive and respiratory syndrome virus increased the immune responses and protective efficacy against virulent PRRSV challenge. Virus Res. 2009, 143:24-32.
37. Woodland D.L. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol. 2004, 25:98-104.
38. Xiao-wen H., Shu-han S., Zhen-lin H., Jun L., Lei J., Feng-juan Z., Ya-nan Z., Ying-jun G. Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine 2005, 23:1649-1656.
39. Zhou Y.J., Hao X.F., Tian Z.J., Tong G.Z., Yoo D., An T.Q., Zhou T., Li G.X., Qiu H.J., Wei T.C., Yuan X.F. Highly virulent porcine reproductive and respiratory syndrome virus emerged in China. Transbound. Emerg. Dis. 2008, 55:152-164.
40. Zhou C., Peng G., Jin X., Tang J., Chen Z. Vaccination with a fusion DNA vaccine encoding hepatitis B surface antigen fused to the extracellular domain of CTLA4 enhances HBV-specific immune responses in mice: implication of its potential use as a therapeutic vaccine. Clin. Immunol. 2010, 137:190-198.